Securities Code: 300505 Securities Abbreviation: Chuanjinno January 1, 2025 to December 31, 2025 Independent Director Performance Report
Kunming Chuanjinno Chemical Co., Ltd. 2025 Annual Independent Director Performance Report (Tian Jun)
To all shareholders and shareholder representatives:
As an independent director of Kunming Chuanjinno Chemical Co., Ltd. (hereinafter referred to as the "Company" or "Chuanjinno"), I have conscientiously fulfilled my duties as an independent director in accordance with the requirements of laws, regulations, normative documents such as the "Company Law," "Securities Law," and the "Administrative Measures for Independent Directors of Listed Companies," as well as the "Articles of Association" and the "Work System for Independent Directors." I actively attended relevant meetings, performed my duties diligently and conscientiously, reviewed various proposals, and expressed opinions on relevant matters, striving to safeguard the overall interests of the Company and the legitimate rights and interests of all shareholders, especially small and medium shareholders. The following is a report on my performance during the period from January 1, 2025, to December 31, 2025:
I. Basic Information
(I) Independent Director Work Experience, Professional Background, and Concurrent Positions
I, Tian Jun, male, Chinese national, born in October 1972, with no permanent overseas residency, hold a master's degree and possess qualifications as an independent director (including independent director qualifications for the Sci-Tech Innovation Board), company secretary, and senior accountant, as well as a certified public accountant qualification. Since July 1994, I have served as an accountant in the Credit Union Securities Department of Wuhan Commercial Bank, an investment project manager in the Securities Department of Wuhan International Trust Investment Company, a project manager for industry analysis in the Information Consulting Department of Wuhan Securities, and a financial manager in the Harbin Branch of Wuhan Securities, and a financial manager in the Planning and Finance Headquarters of Wuhan Securities.
From September 2005 to September 2006, I served as the Compliance Manager of New Era Securities. From October 2006 to October 2007, I served as the Chief Financial Officer (CFO) of Sonac (China) Biotechnology Co., Ltd. From November 2007 to May 2009, I served as the Investment Director of Yunnan Hongxiang Pharmaceutical Co., Ltd. From June 2009 to December 2010, I served as the Secretary of the Board of Directors of Yunnan Hongxiang Yitang Pharmaceutical (Group) Co., Ltd. From December 2010 to December 2019, I served as the Vice President, Financial Controller, and Secretary of the Board of Directors of Yunnan Hongxiang Yitang Pharmaceutical (Group) Co., Ltd. In October 2019, I became an adjunct Master's supervisor at the School of Finance, Yunnan University of Finance and Economics. From January 2020 to December 2025, I served as an independent director of Yunnan Shennong Agricultural Industry Group Co., Ltd. Since September 2023, I have served as an independent director of Kunming Chuanjinno Chemical Co., Ltd. Since January 2026, I have served as the Deputy Director of the First Independent Directors Committee and Audit Professional Committee of the Yunnan Listed Companies Association. I am currently a professional investor and a capital operation consultant for several companies.
(II) Statement of Independence
I possess the independence required by the "Administrative Measures for Independent Directors of Listed Companies," the "Shenzhen Stock Exchange Listed Company Self-Regulatory Guidelines No. 2 - Normative Operation of GEM Listed Companies," and other laws, regulations, normative documents, and the "Articles of Association" and the "Work System for Independent Directors." There are no circumstances that affect my independence. As an independent director of the Company, I do not hold any positions in the Company other than that of an independent director, nor do I hold any positions in the principal shareholder's companies. I have no relationship with the Company and its controlling shareholder that could hinder independent and objective judgment. I can independently perform my duties and am not influenced by the Company's controlling shareholder or any other related parties.